Enrique Rozengurt - Search Results

Year	Number of Results
2002	16
2003	11
2004	11
2005	16
2006	13
2007	12
2008	6
2009	6
2010	10
2011	8
2012	7
2013	8
2014	7
2015	3
2016	4
2017	7
2018	5
2019	6
2020	2
2021	3
2022	3
2023	5
2024	2

1

Obesity and Pancreatic Cancer: Insight into Mechanisms.

Eibl G, Rozengurt E. Eibl G, et al. Among authors: rozengurt e. Cancers (Basel). 2021 Oct 10;13(20):5067. doi: 10.3390/cancers13205067. Cancers (Basel). 2021. PMID: 34680216 Free PMC article. Review.

2

Protein kinase D signaling.

Rozengurt E, Rey O, Waldron RT. Rozengurt E, et al. J Biol Chem. 2005 Apr 8;280(14):13205-8. doi: 10.1074/jbc.R500002200. Epub 2005 Feb 8. J Biol Chem. 2005. PMID: 15701647 Free article. Review. No abstract available.

3

PDX1 associated therapy in translational medicine.

Yu J, Liu SH, Sanchez R, Nemunaitis J, Rozengurt E, Brunicardi FC. Yu J, et al. Among authors: rozengurt e. Ann Transl Med. 2016 Jun;4(11):214. doi: 10.21037/atm.2016.03.51. Ann Transl Med. 2016. PMID: 27386488 Free PMC article. Review.

4

Metformin: review of epidemiology and mechanisms of action in pancreatic cancer.

Eibl G, Rozengurt E. Eibl G, et al. Among authors: rozengurt e. Cancer Metastasis Rev. 2021 Sep;40(3):865-878. doi: 10.1007/s10555-021-09977-z. Epub 2021 Jun 17. Cancer Metastasis Rev. 2021. PMID: 34142285 Free PMC article. Review.

5

Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy.

Sinnett-Smith J, Anwar T, Reed EF, Teper Y, Eibl G, Rozengurt E. Sinnett-Smith J, et al. Among authors: rozengurt e. Mol Cancer Ther. 2022 Nov 3;21(11):1652-1662. doi: 10.1158/1535-7163.MCT-21-0964. Mol Cancer Ther. 2022. PMID: 35999654 Free PMC article.

6

Taste receptor signaling in the mammalian gut.

Rozengurt E, Sternini C. Rozengurt E, et al. Curr Opin Pharmacol. 2007 Dec;7(6):557-62. doi: 10.1016/j.coph.2007.10.002. Epub 2007 Nov 19. Curr Opin Pharmacol. 2007. PMID: 18024184 Free PMC article. Review.

7

Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice.

Teper Y, Ye L, Waldron RT, Lugea A, Sun X, Sinnett-Smith J, Hines OJ, Pandol SJ, Rozengurt E, Eibl G. Teper Y, et al. Among authors: rozengurt e. Sci Rep. 2023 Sep 26;13(1):16144. doi: 10.1038/s41598-023-43498-9. Sci Rep. 2023. PMID: 37752238 Free PMC article.

8

Protein kinase D signaling: multiple biological functions in health and disease.

Rozengurt E. Rozengurt E. Physiology (Bethesda). 2011 Feb;26(1):23-33. doi: 10.1152/physiol.00037.2010. Physiology (Bethesda). 2011. PMID: 21357900 Free PMC article. Review.

9

KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.

Eibl G, Rozengurt E. Eibl G, et al. Among authors: rozengurt e. Semin Cancer Biol. 2019 Feb;54:50-62. doi: 10.1016/j.semcancer.2017.10.007. Epub 2017 Oct 24. Semin Cancer Biol. 2019. PMID: 29079305 Free PMC article. Review.

10

Lipophilic statins inhibit YAP coactivator transcriptional activity in HCC cells through Rho-mediated modulation of actin cytoskeleton.

Benhammou JN, Qiao B, Ko A, Sinnett-Smith J, Pisegna JR, Rozengurt E. Benhammou JN, et al. Among authors: rozengurt e. Am J Physiol Gastrointest Liver Physiol. 2023 Sep 1;325(3):G239-G250. doi: 10.1152/ajpgi.00089.2023. Epub 2023 Jun 27. Am J Physiol Gastrointest Liver Physiol. 2023. PMID: 37366601

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

151 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year